Clinical Trial Update: A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind trial evaluated pregabalin for postherpetic neuralgia; results were posted after completion in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Neuralgia, Postherpetic | Phase 3 | Status: COMPLETED | Results posted: 2009-02-27